Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data

• Baudouin Standaert ,

  * E-mail: baudouin.a.standaert@gsk.com

  Affiliation Health Economics, GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• Jorge A. Gomez,

  Affiliation Medical Department, GlaxoSmithKline Vaccines Latin America, Victoria, Buenos Aires, Argentina

  ⨯
• Marc Raes,

  Affiliation Department of Pediatrics, Jessa Hospital, Hasselt, Belgium

  ⨯
• Serge Debrus,

  Affiliation Vaccine Development and Discovery, GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• F. Raúl Velázquez,

  Affiliation Medical Research Unit on Infectious Diseases, Pediatrics Hospital, National Medical Center-Century XXI, Mexican Institute of Social Security (IMSS), Mexico City, Mexico

  ⨯
• Maarten J. Postma

  Affiliation Unit of Pharmacoepidemiology and Pharmacoeconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯